Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates

被引：174
|
作者：
Dalrymple, Annette
Wild, Edward J.
Joubert, Richard
Sathasivam, Kirupa
Bjorkqvist, Maria
Petersen, Asa
Jackson, Graham S.
Isaacs, Jeremy D.
Kristiansen, Mark
Bates, Gillian P.
Leavitt, Blair R.
Keir, Geoff
Ward, Malcolm
Tabrizi, Sarah J.
机构：
[1] Natl Hosp Neurol & Neurosurg, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England
[2] Proteome Sci PLC, Surrey, England
[3] Inst Neurol, Dept Neurodegenerat, London WC1N 3BG, England
[4] Kings Coll London, Guys Hosp, Sch Med, London WC2R 2LS, England
[5] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden
[6] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada
[7] Natl Hosp Neurol & Neurosurg, Neuroimmunol Lab, London WC1N 3BG, England
来源：
JOURNAL OF PROTEOME RESEARCH | 2007年 / 6卷 / 07期
基金：
英国医学研究理事会; 英国惠康基金;
关键词：
Huntington's disease; plasma; neuroinflammation; proteomics; 2D electrophoresis; LC/MS/MS; MALDI-TOF; ELISA; biomarkers;
D O I：
10.1021/pr0700753
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Huntington's disease (HD) causes widespread CNS changes and systemic abnormalities including endocrine and immune dysfunction. HD biomarkers are needed to power clinical trials of potential treatments. We used multiplatform proteomic profiling to reveal plasma changes with HD progression. Proteins of interest were evaluated using immunoblotting and ELISA in plasma from 2 populations, CSF and R6/2 mice. The identified proteins demonstrate neuroinflammation in HD and warrant further investigation as possible biomarkers.
引用
收藏
页码：2833 / 2840
页数：8
相关论文
共 50 条
  • [41] Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains
    Ratovitski, Tamara
    Chaerkady, Raghothama
    Kammers, Kai
    Stewart, Jacqueline C.
    Zavala, Anialak
    Pletnikova, Olga
    Troncoso, Juan C.
    Rudnicki, Dobrila D.
    Margolis, Russell L.
    Cole, Robert N.
    Ross, Christopher A.
    JOURNAL OF PROTEOME RESEARCH, 2016, 15 (09) : 3266 - 3283
  • [42] Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging
    Jiang, Yuanbing
    Zhou, Xiaopu
    Ip, Fanny C.
    Chan, Philip
    Chen, Yu
    Lai, Nicole C. H.
    Cheung, Kit
    Lo, Ronnie M. N.
    Tong, Estella P. S.
    Wong, Bonnie W. Y.
    Chan, Andrew L. T.
    Mok, Vincent C. T.
    Kwok, Timothy C. Y.
    Mok, Kin Y.
    Hardy, John
    Zetterberg, Henrik
    Fu, Amy K. Y.
    Ip, Nancy Y.
    ALZHEIMERS & DEMENTIA, 2022, 18 (01) : 88 - 102
  • [43] Proteomic profiling of plasma samples in coronary artery disease
    Ragg, Susanne
    Fokin, Vladimir
    Podgorski, Krzysztof
    Schadow, Gunther
    Vitek, Olga
    Kastrati, Adrian
    Schoemig, Albert
    Lorenz-Braun, Siegmund
    Ott, Ilka
    CIRCULATION, 2007, 116 (16) : 575 - 575
  • [44] Discovery of biomarker candidates within disease by protein profiling:: Principles and concepts
    Marko-Varga, G
    Lindberg, H
    Löfdahl, CG
    Jönsson, P
    Hansson, L
    Dahlbäck, M
    Lindquist, E
    Johansson, L
    Foster, M
    Fehniger, TE
    JOURNAL OF PROTEOME RESEARCH, 2005, 4 (04) : 1200 - 1212
  • [45] Peptidomic and Proteomic Profiling of the Juvenile Rheumatoid Arthritis (JRA) Synovial Fluid Reveals Transthyretin (TTR) as Potential Biomarker of the Disease
    Clement, Cristina
    Moncrieffe, Halima
    Becerra, Aniuska
    Stern, Lawrence
    Santambrogio, Laura
    FASEB JOURNAL, 2015, 29
  • [46] Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+dermatomyositis
    Zhang, Panpan
    Li, Mengdi
    Zhang, Yuqi
    Lian, Chaofeng
    Sun, Jinlei
    He, Yujie
    Hu, Wenlu
    Wang, Limei
    Li, Tianfang
    Liu, Shengyun
    Zhang, Yusheng
    CLINICAL RHEUMATOLOGY, 2023, 42 (08) : 2145 - 2154
  • [47] Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis
    Panpan Zhang
    Mengdi Li
    Yuqi Zhang
    Chaofeng Lian
    Jinlei Sun
    Yujie He
    Wenlu Hu
    Limei Wang
    Tianfang Li
    Shengyun Liu
    Yusheng Zhang
    Clinical Rheumatology, 2023, 42 : 2145 - 2154
  • [48] Quantitative Proteomic Profiling Reveals Novel Plasmodium falciparum Surface Antigens and Possible Vaccine Candidates
    Nilsson, Sandra K.
    Ahmad, Rushdy
    Dantzler, Kathleen
    Lukens, Amanda K.
    De Niz, Mariana
    Szucs, Matthew J.
    Jin, Xiaoying
    Cotton, Joanne
    Hoffmann, Dietmar
    Bric-Furlong, Eva
    Oomen, Ray
    Parrington, Mark
    Milner, Dan
    Neafsey, Daniel E.
    Carr, Steven A.
    Wirth, Dyann F.
    Marti, Matthias
    MOLECULAR & CELLULAR PROTEOMICS, 2018, 17 (01) : 57 - 74
  • [49] Saccadic latencies as a biomarker for Huntington's and Parkinson's disease
    Antoniades, C. A.
    Xu, Z.
    Carpenter, R. H. S.
    Barker, R. A.
    MOVEMENT DISORDERS, 2008, 23 (01) : S188 - S188
  • [50] Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling
    Meuwis, Marie-Alice
    Fillet, Marianne
    Geurts, Pierre
    de Seny, Dominique
    Lutteri, Laurence
    Chapelle, Jean-Paul
    Bours, Vincent
    Wehenkel, Louis
    Belaiche, Jacques
    Malaise, Michel
    Louis, Edouard
    Merville, Marie-Paule
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (09) : 1422 - 1433
12345